pharma · Fibromyalgia · Primary Fibromyalgia · TNXP
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals is a pharma organization headquartered in Berkeley Heights, USA. It trades on NYSE under ticker TNXP. Primary therapeutic focus areas include Fibromyalgia, Primary Fibromyalgia, PTSD, Acute Stress R
200 Connell Dr, Berkeley Heights, New Jersey 07922, US HQ
2007 Founded
154 Employees
Public company Type
TNXP · NYSE Ticker
Company details
- Status
- Public
- HQ
- 200 Connell Dr, Berkeley Heights, New Jersey 07922, US
- Founded
- 2007
- Employees
- 154
- Programs
- 30
- Drugs
- 10
- Patents
- 86
TNX-2110
Phase 1 · mab · Detection of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 in Individuals Exposed to SARS-CoV-2
TNX-2110 for Detection of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 in Individuals Exposed to SARS-CoV-2 is a Phase 1 program (mab) at Tonix Pharmaceuticals Holding with 1 ClinicalTrials.gov record(s).
Internal code TNX-CA-C201
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Tonix Pharmaceuticals Holding
- Phase
- Phase 1
- Modality
- mab
- Indication
- Detection of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 in Individuals Exposed to SARS-CoV-2
- Status
- terminated
- Trials
- 1